Company intelligence / Profile preview

Hanyang Securities

Seoul, South Korea

Ownership: Private
Employees: ~450
Development stage: Other

Overview

Hanyang Securities is a South Korea-based financial services firm that provides securities brokerage, investment banking, and wealth management services. Founded in 1956, the company is a subsidiary of the Hanyang University Foundation and is listed on the Korea Exchange. While not a biotechnology or pharmaceutical developer, Hanyang Securities is active in the life sciences sector as an underwriter for initial public offerings (IPOs) and a provider of corporate finance for Korean healthcare companies. The firm offers research coverage and investment advisory services across various industries, including technology and healthcare. It is recognized for its role in supporting the growth of the Korean biotech ecosystem through capital market activities.

Industry: Investors

Beyond the preview

Go deeper on Hanyang Securities.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hanyang Securities.

Explore the full profile